Literature DB >> 30686635

Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife.

Mark W Smithson1, Andrew J Basinki2, Scott L Nuismer3, James J Bull4.   

Abstract

Transmission is a potential property of live viral vaccines that remains largely unexploited but may lie within the realm of many engineering designs. While likely unacceptable for vaccines of humans, transmission may be highly desirable for vaccines of wildlife, both to protect natural populations and also to limit zoonotic transmissions into humans. Defying intuition, transmission alone does not guarantee that a vaccine will perform well: the benefit of transmission over no transmission depends on and increases with the basic reproductive number of the vaccine, R0. The R0 of an infectious agent in a homogeneous population is typically considered to be a fixed number, but some evidence suggests that dissemination of transmissible vaccines may change through time. One obvious possibility is that transmission will be greater from hosts directly vaccinated than from hosts who acquire the vaccine passively, but other types of change might also accrue. Whenever transmission changes over time, the R0 estimated from directly vaccinated hosts will not reflect the vaccine's long term impact. As there is no theory on the consequences of changing transmission rates for a vaccine, we derive conditions for a transmissible vaccine with varying transmission rates to protect a population from pathogen invasion. Being the first in the transmission chain, the R0 from directly vaccinated hosts has a larger effect than those from later steps in the chain. This mathematical property reveals that a transmissible vaccine with low long term transmission may nonetheless realize a big impact if early transmission is high. Furthermore, there may be ways to artificially elevate early transmission, thereby achieving high herd immunity from transmission while ensuring that the vaccine will ultimately die out.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Gene therapy; Infectious vaccine; Population dynamics

Mesh:

Substances:

Year:  2019        PMID: 30686635      PMCID: PMC6492562          DOI: 10.1016/j.vaccine.2019.01.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Efficient immunization strategies for computer networks and populations.

Authors:  Reuven Cohen; Shlomo Havlin; Daniel Ben-Avraham
Journal:  Phys Rev Lett       Date:  2003-12-09       Impact factor: 9.161

2.  Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.

Authors:  T P Monath; I Levenbook; K Soike; Z X Zhang; M Ratterree; K Draper; A D Barrett; R Nichols; R Weltzin; J Arroyo; F Guirakhoo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.

Authors:  J Bárcena; M Morales; B Vázquez; J A Boga; F Parra; J Lucientes; A Pagès-Manté; J M Sánchez-Vizcaíno; R Blasco; J M Torres
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease.

Authors:  J M Torres; C Sánchez; M A Ramírez; M Morales; J Bárcena; J Ferrer; E Espuña; A Pagès-Manté; J M Sánchez-Vizcaíno
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

5.  Transmission of two Australian strains of murine cytomegalovirus (MCMV) in enclosure populations of house mice (Mus domesticus).

Authors:  L N Farroway; S Gorman; M A Lawson; N L Harvey; D A Jones; G R Shellam; G R Singleton
Journal:  Epidemiol Infect       Date:  2005-08       Impact factor: 2.451

Review 6.  Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.

Authors:  C E Rupprecht; C A Hanlon; D Slate
Journal:  Dev Biol (Basel)       Date:  2004

Review 7.  Rationalizing the development of live attenuated virus vaccines.

Authors:  Adam S Lauring; Jeremy O Jones; Raul Andino
Journal:  Nat Biotechnol       Date:  2010-06-07       Impact factor: 54.908

8.  Autonomous targeting of infectious superspreaders using engineered transmissible therapies.

Authors:  Vincent T Metzger; James O Lloyd-Smith; Leor S Weinberger
Journal:  PLoS Comput Biol       Date:  2011-03-17       Impact factor: 4.475

Review 9.  Self-disseminating vaccines for emerging infectious diseases.

Authors:  Aisling A Murphy; Alec J Redwood; Michael A Jarvis
Journal:  Expert Rev Vaccines       Date:  2015-11-02       Impact factor: 5.217

Review 10.  Current status of rabies and prospects for elimination.

Authors:  Anthony R Fooks; Ashley C Banyard; Daniel L Horton; Nicholas Johnson; Lorraine M McElhinney; Alan C Jackson
Journal:  Lancet       Date:  2014-05-11       Impact factor: 79.321

View more
  1 in total

Review 1.  Self-disseminating vaccines to suppress zoonoses.

Authors:  Scott L Nuismer; James J Bull
Journal:  Nat Ecol Evol       Date:  2020-07-27       Impact factor: 19.100

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.